Skip to main content
logo
Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
1.810
+0.030 (1.69%)
At close: Feb 20, 2026, 4:00 PM EST
1.807
-0.003 (-0.17%)
After-hours: Feb 20, 2026, 8:00 PM EST

Lineage Cell Therapeutics Market Cap

Lineage Cell Therapeutics has a market cap or net worth of $438.61 million as of February 20, 2026. Its market cap has increased by 252.02% in one year.

Market Cap
438.61M
Enterprise Value
400.75M
1-Year Change
252.02%
Ranking
#3153
Category
Small-Cap
Stock Price
$1.81

Market Cap Chart

Since December 1, 1998, Lineage Cell Therapeutics's market cap has increased from $147.40M to $438.61M, an increase of 197.57%. That is a compound annual growth rate of 4.08%.

History

DateMarket Cap% Change
Feb 19, 2026410.00M6.60%
Dec 31, 2025384.60M305.70%
Dec 31, 202494.80M-50.29%
Dec 29, 2023190.70M-4.12%
Dec 30, 2022198.90M-51.84%
Dec 31, 2021413.00M56.44%
Dec 31, 2020264.00M98.05%
Dec 31, 2019133.30M15.01%
Dec 31, 2018115.90M-57.51%
Dec 29, 2017272.80M-26.90%
Dec 30, 2016373.20M-4.09%
Dec 31, 2015389.10M25.52%
Dec 31, 2014310.00M28.15%
Dec 31, 2013241.90M51.38%
Dec 31, 2012159.80M-45.26%
Dec 30, 2011291.90M-26.38%
Dec 31, 2010396.50M181.41%
Dec 31, 2009140.90M234.68%
Dec 31, 200842.10M347.87%
Dec 31, 20079.40M54.10%
Dec 29, 20066.10M10.91%
Dec 30, 20055.50M-79.55%
Dec 31, 200426.90M43.09%
Dec 31, 200318.80M-10.05%
Dec 31, 200220.90M-60.79%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Assembly Biosciences454.74M
Lyell Immunopharma454.62M
DiaMedica Therapeutics451.13M
Solid Biosciences444.87M
Autolus Therapeutics444.46M
Kyverna Therapeutics438.75M
Invivyd437.08M
Upstream Bio436.63M
Market Cap Rankings